Effects of senescent secretory phenotype acquisition on human retinal pigment epithelial stem cells
- 16 November 2018
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 10 (11) , 3173-3184
Abstract
Regenerative medicine approaches based on mesenchymal stem cells (MSCs) are being investigated to treat several aging-associated diseases, including age-related macular degeneration (AMD). Loss of retinal pigment epithelium (RPE) cells occurs early in AMD, and their transplant has the potential to slow disease progression.The human RPE contains a subpopulation of cells - adult RPE stem cells (RPESCs) - that are capable of self-renewal and of differentiating into RPE cells in vitro. However, age-related MSC changes involve loss of function and acquisition of a senescence-associated secretory phenotype (SASP), which can contribute to the maintenance of a chronic state of low-grade inflammation in tissues and organs.In a previous study we isolated, characterized, and differentiated RPESCs. Here, we induced replicative senescence in RPESCs and tested their acquisition of the senescence phenotype and the SASP as well as the differentiation ability of young and senescent RPESCs.Senescent RPESCs showed a significantly reduced proliferation ability, high senescence-associated β-galactosidase activity, and SASP acquisition. RPE-specific genes were downregulated and p21 and p53 protein expression was upregulated.These findings document the effects of senescence and SASP acquisition on RPESC differentiation ability and highlight the need for a greater understanding of their role in AMD pathogenesis.Keywords
This publication has 58 references indexed in Scilit:
- Aged macular degeneration: current therapeutics for management and promising new drug candidatesDrug Discovery Today, 2017
- DNA damage response and autophagy in the degeneration of retinal pigment epithelial cells—Implications for age-related macular degeneration (AMD)Ageing Research Reviews, 2017
- Advances in Age-related Macular Degeneration Understanding and TherapyUS Ophthalmic Review, 2017
- Cellular Senescence in Age‐Related Macular Degeneration: Can Autophagy and DNA Damage Response Play a Role?Oxidative Medicine and Cellular Longevity, 2017
- Geo-Epidemiology of Age-Related Macular Degeneration: New Clues Into the PathogenesisAmerican Journal of Ophthalmology, 2016
- Long-Term Outcomes of Treatment of Neovascular Age-Related Macular DegenerationOphthalmology, 2015
- Age-related macular degenerationThe Lancet, 2012
- Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysisBMC Ophthalmology, 2010
- Evaluation of the Clinical Age-Related Maculopathy Staging SystemOphthalmology, 2006
- Risk factors associated with age-related macular degenerationOphthalmology, 2000